X4 Pharmaceuticals Balance Sheet (2017-2025) | XFOR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Accumulated Depreciation (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)	114.94M	95.20M	76.39M	81.79M	66.43M	47.38M	79.86M	121.72M	93.41M	136.43M	131.58M	99.22M	60.49M	147.22M	97.41M	55.70M	40.26M	39.22M	69.63M	217.05M
Receivables - Net (Quarter)																1.07M	0.51M	1.15M	0.89M	0.57M
Receivables - Other (Quarter)	0.77M	1.05M	0.65M	0.75M	0.87M	0.84M	0.91M	1.15M	0.66M	0.82M	0.39M	0.56M	0.70M	0.85M	1.07M	0.64M	0.67M	0.72M	0.71M
Receivables (Quarter)												0.56M		0.85M	1.07M	1.71M	1.17M	1.86M	1.61M	0.57M
Inventory (Quarter)														0.83M	2.44M	2.82M	3.09M	3.17M	4.08M	4.48M
Prepaid Assets (Quarter)	4.25M	5.16M	3.66M	5.34M	3.59M	4.36M	4.95M	5.81M	4.16M	5.52M	5.80M	7.30M	5.76M	4.98M	4.48M	5.59M	4.48M	4.96M	4.92M	3.53M
Current Assets (Quarter)	119.96M	101.37M	80.70M	87.88M	70.88M	52.59M	85.72M	128.68M	98.22M	147.65M	147.87M	122.08M	87.33M	175.42M	142.97M	112.17M	95.70M	72.94M	132.81M	261.58M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	1.79M	1.75M	1.63M	1.51M	1.40M	1.31M	1.19M	1.10M	0.99M	0.87M	0.77M	0.74M	0.74M	0.81M	0.82M	0.78M	0.49M	0.25M	0.22M	0.18M
Goodwill (Quarter)	27.11M	27.11M	27.11M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M
Intangibles (Quarter)														10.40M	10.20M	10.00M	9.81M	9.60M	9.40M	9.30M
Goodwill & Intangibles (Quarter)	27.11M	27.11M	27.11M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	17.35M	27.75M	27.55M	27.35M	27.16M	26.95M	26.75M	26.65M
Other Non-Current Assets (Quarter)	2.39M	2.00M	2.00M	1.72M	1.65M	1.80M	1.54M	1.23M	1.00M	1.08M	1.24M	1.44M	1.49M	1.79M	2.36M	2.08M	3.01M	2.35M	1.97M	0.69M
Non-Current Assets (Quarter)	41.08M	40.29M	39.82M	29.30M	28.74M	28.43M	27.69M	26.91M	26.18M	25.75M	25.42M	25.18M	24.85M	35.20M	35.19M	34.27M	34.32M	32.23M	30.75M	28.88M
Assets (Quarter)	161.03M	141.66M	120.52M	117.18M	99.62M	81.02M	113.41M	155.59M	124.41M	173.40M	173.29M	147.26M	112.18M	210.61M	178.16M	146.45M	130.01M	105.17M	163.56M	290.46M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.09M	2.53M	2.42M	4.28M	3.57M	3.68M	3.80M	7.78M	5.99M	5.11M	8.13M	8.95M	8.94M	7.99M	8.58M	8.62M	11.12M	7.71M	5.05M	5.70M
Payables (Quarter)	3.09M	2.53M	2.42M	4.28M	3.57M	3.68M	3.80M	7.78M	5.99M	5.11M	8.13M	8.95M	8.94M	7.99M	8.58M	8.62M	11.12M	7.71M	5.05M	5.70M
Accumulated Expenses (Quarter)	10.71M	9.61M	9.07M	7.87M	6.88M	8.58M	9.13M	12.03M	11.76M	15.23M	16.18M	12.82M	13.47M	19.74M	19.46M	23.00M	12.61M	13.06M	16.66M	18.60M
Other Accumulated Expenses (Quarter)
Short term Debt (Quarter)			0.69M	0.80M	3.42M	8.61M	14.62M	1.31M	0.55M	0.76M
Current Leases (Quarter)	0.88M	0.98M	1.04M	1.07M	1.11M	1.14M	1.16M	1.20M	1.18M	1.15M	1.12M	1.10M	1.13M	1.17M	1.22M	1.25M	1.30M	1.37M	1.20M	0.99M
Current Deferred Revenue (Quarter)																	0.85M	0.75M	0.59M	0.46M
Total Current Liabilities (Quarter)	14.67M	13.12M	13.23M	14.02M	14.97M	22.00M	28.71M	22.32M	19.48M	22.25M	25.43M	22.86M	23.54M	28.90M	29.26M	32.88M	25.88M	22.90M	23.51M	25.76M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)																	0.95M	0.83M	0.79M	0.62M
Preferred Stock Liabilities (Quarter)	1.88M	1.88M
Operating Leases (Quarter)	5.58M	5.35M	6.11M	4.78M	4.48M	5.28M	4.96M	3.60M	4.55M	3.12M	3.96M	2.61M	2.32M	2.03M	1.76M	1.41M	1.11M	2.18M	0.10M	0.99M
Other Non-Current Liabilities (Quarter)	0.49M	0.43M	0.50M		0.65M	0.31M	0.31M	23.14M	17.69M	1.47M	1.08M	15.68M	29.44M	9.22M	1.22M	13.76M	2.92M	0.28M	0.96M	0.53M
Total Non-Current Liabilities (Quarter)	53.61M	52.01M	51.34M	52.76M	49.26M	50.63M	51.24M	58.39M	55.04M	104.39M	104.62M	80.48M	81.71M	106.94M	117.33M	110.54M	104.14M	100.91M	100.98M	103.65M
Total Liabilities (Quarter)	54.10M	52.45M	51.84M	52.76M	49.91M	50.95M	51.56M	81.53M	72.73M	105.86M	105.70M	96.16M	111.15M	116.16M	118.54M	124.30M	107.07M	101.20M	101.94M	104.17M
Shareholder's Equity
Total Debt (Quarter)			0.69M	0.80M	3.42M	8.61M	14.62M	1.31M	0.55M	0.76M
Common Equity (Quarter)	105.06M	87.34M	68.68M	64.41M	49.71M	30.07M	61.85M	74.05M	51.68M	67.53M	67.59M	51.10M	1.04M	94.45M	59.62M	22.15M	22.94M	3.97M	61.62M	186.29M
Shareholder's Equity (Quarter)	105.06M	87.34M	68.68M	64.41M	49.71M	30.07M	61.85M	74.05M	51.68M	67.53M	67.59M	51.10M	1.04M	94.45M	59.62M	22.15M	22.94M	3.97M	61.62M	186.29M
Liabilities and Shareholders Equity (Quarter)	161.03M	141.66M	120.52M	117.18M	99.62M	81.02M	113.41M	155.59M	124.41M	173.40M	173.29M	147.26M	112.18M	210.61M	178.16M	146.45M	130.01M	105.17M	163.56M	290.46M
Retained Earnings (Quarter)	-212.85M	-232.49M	-252.66M	-282.87M	-0.12M	-0.12M	-0.12M	-0.12M	-0.12M	-456.47M	-0.12M	-477.90M	-529.70M	-438.84M	-475.50M	-0.12M	-515.07M	-0.14M	-570.60M	-0.11M
Treasury Shares (Quarter)	1.14M	1.00M	0.91M	0.93M	1.94M	1.77M	1.40M	1.68M	5.84M	5.86M	5.57M	3.12M	8.37M	8.22M	8.12M	0.20M	0.33M	0.33M	0.10M	0.07M
Shares Outstanding (Quarter)	23.43M	24.58M	24.71M	28.13M	30.81M	30.99M	68.73M	4.06M	122.21M	164.42M	164.71M	5.58M	5.60M	5.61M	5.62M	5.70M	5.79M	7.96M	25.15M	90.91M

Research Tools

X4 Pharmaceuticals Balance Sheet (2017-2025) | XFOR

Create an account

Sign In

Reset Password